19 June 2013
Keywords: acambis, six, month, loss, down, costs, fall
Article | 01 October 2007
UK vaccines developer Acambis loss for the six-month period ended June 30 was L19.3 million ($38.9 million), down 15.7% from the deficit it
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 May 2007
© 2013 thepharmaletter.com